Is coronary artery disease inevitable in type 2 diabetes? From a glucocentric to a holistic view on patient management
G Ferrannini, A Norhammar, V Gyberg… - Diabetes …, 2020 - Am Diabetes Assoc
… In addition, impaired glucose tolerance (IGT) has been … ) can prevent or postpone the
development of type 2 diabetes and, … care cohort recruited in 14 European countries in 2014–2015 …
development of type 2 diabetes and, … care cohort recruited in 14 European countries in 2014–2015 …
Incidence of diabetes mellitus and associated risk factors in the adult population of the Basque country, Spain
…, Diabetes Epidemiology Group García-Castaño … - Scientific reports, 2021 - nature.com
… The IDF warns that the risk of developing cardiovascular events is higher in these people not
receiving neither treatment nor preventive measures 20 thereby… Impaired glucose tolerance …
receiving neither treatment nor preventive measures 20 thereby… Impaired glucose tolerance …
Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health …
TTW van Herpt, S Ligthart, MJG Leening… - BMJ Open Diabetes …, 2020 - drc.bmj.com
… . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with
impaired glucose tolerance. N Engl J Med 2001;344:1343–50.doi:10.1056/NEJM200105033441801…
impaired glucose tolerance. N Engl J Med 2001;344:1343–50.doi:10.1056/NEJM200105033441801…
Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population
T Kawahara, G Suzuki, S Mizuno, T Inazu, F Kasagi… - bmj, 2022 - bmj.com
… We defined impaired glucose tolerance as meeting all three … for preventing the development
of type 2 diabetes after … range in Japan is 2-10 μU/mL,25 but in Europe and the US it …
of type 2 diabetes after … range in Japan is 2-10 μU/mL,25 but in Europe and the US it …
Lifestyle and progression to type 2 diabetes in a cohort of workers with prediabetes
M Bennasar-Veny, S Fresneda, A López-González… - Nutrients, 2020 - mdpi.com
… : impaired fasting plasma glucose (FPG), impaired glucose … of BMI and regular PA in
preventing the progression to T2D. … Furthermore, we did not perform an oral glucose tolerance …
preventing the progression to T2D. … Furthermore, we did not perform an oral glucose tolerance …
Consensus report: definition and interpretation of remission in type 2 diabetes
MC Riddle, WT Cefalu, PH Evans… - … & Metabolism, 2022 - academic.oup.com
… to prevent emergence or re-emergence of overt diabetes is the possibility of … protection
against β-cell deterioration by pharmacotherapy has yet to be convincingly proven and preventive …
against β-cell deterioration by pharmacotherapy has yet to be convincingly proven and preventive …
Metformin for diabetes prevention: update of the evidence base
U Hostalek, I Campbell - Current medical research and opinion, 2021 - Taylor & Francis
… to metformin (mostly with impaired glucose tolerance [IGT]) … main subject of prevention or
delay of type 2 diabetes. The effects … in defined circumstances, while the ESC/EASD guideline …
delay of type 2 diabetes. The effects … in defined circumstances, while the ESC/EASD guideline …
A disease state approach to the pharmacological management of type 2 diabetes in primary care: a position statement by Primary Care Diabetes Europe
S Seidu, X Cos, S Brunton, SB Harris, SPO Jansson… - … Care Diabetes, 2021 - Elsevier
… Type 2 diabetes and its associated comorbidities are … In many countries, most patients with
type 2 diabetes are … elevated cardiovascular risk in people with type 2 diabetes and aims to …
type 2 diabetes are … elevated cardiovascular risk in people with type 2 diabetes and aims to …
Pharmacotherapy of type 2 diabetes: An update and future directions
A DeMarsilis, N Reddy, C Boutari, A Filippaios… - Metabolism, 2022 - Elsevier
Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and social
impact for which multiple conventional and novel pharmacotherapies are currently available; …
impact for which multiple conventional and novel pharmacotherapies are currently available; …
Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings
… Overall risk factor management was poor in people with type 2 diabetes. Greater use of …
People with type 2 diabetes and without cardio-renal disease may benefit greatly from CVD …
People with type 2 diabetes and without cardio-renal disease may benefit greatly from CVD …